Related Experiment Video
Updated: Mar 20, 2026
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
9.8K
Pharmacologic Therapy of Type 2 Diabetes
Jennifer J Wright1, Tracy S Tylee2
1Department of Medicine, Division of General Internal Medicine, University of Washington, 4245 Roosevelt Way Northeast, Seattle, WA 98105, USA.
The Medical Clinics of North America
|May 29, 2016
Summary
Type 2 diabetes (T2DM) management involves lifestyle changes and medications to control blood glucose and prevent complications. Informed pharmacotherapy decisions are crucial for patients to lead healthy lives despite this costly condition.
Area of Science:
- Endocrinology
- Pharmacology
- Public Health
Background:
- Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder with significant individual and societal costs.
- Effective management of T2DM and its complications is complex, requiring multifaceted treatment strategies.
- Pharmacotherapy is a cornerstone in controlling hyperglycemia and mitigating long-term diabetic sequelae.
Purpose of the Study:
- To underscore the critical importance of informed pharmacotherapy decision-making in Type 2 diabetes management.
- To highlight the role of medications in preventing diabetes-related complications.
- To emphasize the economic burden of T2DM and the value of appropriate treatment.
Main Methods:
- This abstract does not detail specific methods but discusses the general principles of T2DM pharmacotherapy.
- It emphasizes the integration of lifestyle modifications with pharmacological interventions.
- The focus is on the clinical and economic impact of treatment choices.
Main Results:
- Appropriate pharmacotherapy, alongside lifestyle changes, is essential for effective blood glucose control in T2DM.
- Informed treatment decisions contribute to preventing serious diabetes-related complications.
- Effective management can enable patients to lead healthy lives despite the disease.
Conclusions:
- Making judicious pharmacotherapy choices is paramount for optimizing outcomes in Type 2 diabetes.
- Addressing the complexities of T2DM treatment is vital for patient well-being and reducing healthcare expenditures.
- Successful T2DM management empowers individuals to live full lives.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
01:22Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
908
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
908
01:22Diabetes Mellitus: Overview and Type I Subtype
5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
01:24Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
01:36Carbohydrate Metabolism
14.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.9K